Cardiotoxicity is supposed to be the most important limiting factor in chemotherapy with anthracycline derivatives. The left ventricular ejection fraction was measured several times by means of radionuclid - scintigraphy in 24 patients treated with epirubicin - cisplatinum. Pathologic values have been found only in 3 patients, but no correlation with age, cumulative dose or dose/m2 of body surface could be demonstrated.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[on problem
4
problem cardiotoxicity
4
cardiotoxicity epirubicin-cisplatin]
4
epirubicin-cisplatin] cardiotoxicity
4
cardiotoxicity supposed
4
supposed limiting
4
limiting factor
4
factor chemotherapy
4
chemotherapy anthracycline
4
anthracycline derivatives
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!